| Literature DB >> 19718299 |
Syed A H Rizvi1, Sajid Sultan, Mirza N Zafar, Bashir Ahmed, Syed M Faiq, Kehkashan Z Hossain, Syed A A Naqvi.
Abstract
OBJECTIVES: To describe an evaluation protocol for pediatric stone formers for risk assessment and management strategies.Entities:
Keywords: Evaluation; pediatric; urolithiasis
Year: 2007 PMID: 19718299 PMCID: PMC2721575 DOI: 10.4103/0970-1591.36717
Source DB: PubMed Journal: Indian J Urol ISSN: 0970-1591
Figure 1Evaluation protocol of pediatric stone formers
Normal values for serum and 24h urine chemistry
| Blood chemistry | Normal ranges | 24h urine biochemistry | up to age 9 | >9 – 15 |
|---|---|---|---|---|
| S. Urea (mg/dl) | 12–45 | Urine volume (ml/24h) | 500 – 1000 | 700 – 1400 |
| S. Creatinine (mg/dl) | 0.3 – 1.0 | Urinary ammonium (mmol/24h) | 20 – 50 | 20 – 50 |
| S. Uric Acid (mg/dl) | Uric Acid (mg/kg/24h) | 10 – 15 | 10 – 15 | |
| 1 – 5 years | 1.7 – 5.8 | Calcium (mg/kg/24h) | 1.5 – 4.5 | 1.5 – 4.0 |
| 6 – 11 years | 2.2 – 6.6 | Phosphorus (mg/kg/24h) | 8 – 18 | 8 – 18 |
| < 12 years | 3.0 – 7.7 | Protein (mg/24h) | < 150 | < 150 |
| S. Calcium (mg/dl) | 8.8 – 10.8 | Sodium (mEq/24h) | 40 – 90 | 60 – 175 |
| S. Phosphorus (mg/dl) | 4.0 – 7.0 | Potassium (mEq/24h) | 10 – 50 | 20 – 75 |
| S. Magnesium (mg/dl) | 1.5 – 3.1 | Oxalate (mg/kg/24h) | 0.3 – 1.0 | 0.5 – 1.5 |
| S. Sodium (mEq/L) | Citrate (mg/kg/24h) | 5 – 8 | 7 – 15 | |
| Up to 12 years | 138 – 145 | Magnesium (mg/kg/24h) | 1.2 – 2.5 | 1.0 – 1.5 |
| > 12 years | 136 – 146 | pH | 6 – 7 | 6 – 7 |
| S. Potassium (mEq/L) | 3.5 – 5.0 | |||
| Chloride (mEq/L) | 98 – 107 | |||
| Bicarbonate (mEq/L) | 20 – 28 | |||
| T. Protein (gm/dl) | ||||
| 1 – 7 years | 6.1 – 7.9 | |||
| 8 – 12 years | 6.4 – 8.1 | |||
| 13 – 19 years | 6.6 – 8.2 | |||
| S. Albumin (gm/dl) | 3.5 – 5.0 |
Clinical presentation in pediatric stone formers
| Normal renal function n = 2216 | Renal failure n = 402 | |||
|---|---|---|---|---|
| No. | % | No. | % | |
| Fever | 778 | 35.1 | 228 | 56.7 |
| Flank pain | 778 | 35.1 | 222 | 55.2 |
| Vague abdominal pain | 817 | 36.9 | 51 | 12.7 |
| Hematuria | 685 | 30.9 | 65 | 16.2 |
| Nausea, vomiting | 501 | 22.6 | 154 | 38.3 |
| Dysuria/frequency | 685 | 30.9 | 144 | 35.8 |
| Shortness of breath | - | - | 153 | 38.0 |
| Oligo-anuric | - | - | 105 | 26.1 |
| Swelling | - | - | 48 | 11.9 |
Distribution of calculi in the urinary tract
| Normal renal failure n=2216 (%) | Renal failure n=402 (%) | |
|---|---|---|
| Unilateral | 1431 (65) | 57 (14) |
| Upper tract | 1028 (51) | 52 (13) |
| Bladder | 303 (14) | 5 (1) |
| Bilateral | 466 (21) | 243 (60) |
| Renal | 442 (20) | 210 (52) |
| Ureteric | 20 (0.9) | 15 (3.5) |
| Stone at multiple sites | 319 (14) | 102 (26) |
| Upper tract | 172 (7.5) | 42 (11) |
| Upper Tract + Bladder | 147 (6.5) | 60 (15) |
| Total bladder | 450 (20) | 65 (16) |
Metabolic risk factors in 24h urine of pediatric stone formers
| n= 1892 Parameter | Mean ± SD | Overall n = 1892 | AHU stone formers n = 174 | CaOx stone formers n = 264 |
|---|---|---|---|---|
| Urine volume | 975.8 ± 756 | ↓31% | ↓49% | ↓18% |
| Uric acid | 14.0 ± 23.0 | ↑26% | ↑45% | ↑17% |
| Calcium | 4.1 ± 9.6 | ↑26%↓20% | ↑14%↓29% | ↑30%↓13% |
| Phosphorus | 14.4 ± 25.2 | ↑19%↓22% | ↑29%↓20 | ↑12%↓16% |
| Sodium | 65.5 ± 36.0 | ↑12%↓38% | ↑5%↓54% | ↑19%↓21% |
| Potassium | 15.9 ± 10.3 | ↓47% | ↓40% | ↓40% |
| Magnesium | 3.3 ± 12.6 | ↓11% | ↓17% | ↓9% |
| Ammonium | 29.7 ± 24.6 | ↑11% | ↑13% | ↑15% |
| Protein | 214 ± 322.9 | ↑39% | ↑41% | ↑37% |
| Oxalate | 1.90 ± 6.2 | ↑43% | ↑60% | ↑36% |
| Citrate | 3.58 ± 13.9 | ↓87% | ↓83% | ↓90% |
| PH | 6.07 ± 2.4 | ↓50% ↑9% | ↑15%↓48% | ↑8%↓49% |
Figure 2Distribution of pure renal stones in different age groups